Oligodendroglioma surgery

Oligodendroglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Oligodendroglioma from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging
History & Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Oligodendroglioma surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Oligodendroglioma surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Oligodendroglioma surgery
CDC on Oligodendroglioma surgery
Oligodendroglioma surgery in the news
Blogs on Oligodendroglioma surgery
Directions to Hospitals Treating Oligodendroglioma
Risk calculators and risk factors for Oligodendroglioma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Surgery is not the first-line treatment option for patients with oligodendroglioma. CSF shunting is usually reserved for patients with hydrocephalus.

Surgery

• Surgery is not the first-line treatment option for patients with oligodendroglioma
• Because of their diffusely infiltrating nature, oligodendrogliomas cannot be completely resected and are not curable by surgical excision.
• The aim of surgery is to:
  • Make a definitive diagnosis
  • Debulk the tumor to relieve elevated intracranial pressure
  • Reduce the tumor mass as a precursor to adjuvant treatment

References

Template:WikiDoc Sources